The Massachusetts Institute of Technology has developed a new type of vaccine that can be adapted to fight any epidemic in a short time.
As reported in a scientific article published in the journal Proceedings of the National Academy of Sciences, scientists managed, in particular, to obtain antigens against Ebola pathogens, swine flu and toxoplasma. The efficiency of their application is close to 100%.
The method consists in “programming” the structure of the matrix RNA to synthesize proteins that activate the immune system to fight a specific disease. The scientists propose to use nanoparticles as a “delivery vehicle” for the RNA structure into the cell.
RNA-type vaccines can be administered intramuscularly. So far, they have been successfully tested on mice. According to the results of a series of experiments, resistance to Ebola, swine flu, and toxoplasma viruses was recorded in the experimental mice.
Scientists note that RNA vaccines are less harmful than traditional DNA vaccines because they do not alter the cell genome and do not lead to subsequent mutations.
Original source: 9tv.co.il
